You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
20 October 2026 - Abbott Laboratories (NYSE: ABT), a global healthcare company, said on Tuesday that Cologuard Plus has received CE Mark approval under the European Union's In Vitro Diagnostic Medical Devices Regulation, clearing the way for its...
20 October 2026 - Solventum Corporation (NYSE: SOLV), a US-based company involved in advanced wound healing, announced on Monday that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of Restrata Synthetic El...
20 October 2026 - Sisram Medical Ltd (HKG: 1696), a China-based global wellness group offering Energy-Based Devices (EBDs), injectables, and other complementary solutions, announced on Monday that China's National Medical Products Administration...
20 October 2026 - US-based tech firm Oracle Corporation (NYSE: ORCL) announced on Tuesday an agreement with UK-based pharmaceutical company AstraZeneca (LON: AZN) to explore how AI and real-world data can help clinicians identify eligible patients fo...
19 October 2026 - Pharmaceutical research and development company AbbVie (NYSE: ABBV) reported on Monday that its investigational dual-targeting therapy ABBV-466 achieved higher endoscopic remission rates than either anti-IL-23 or anti-α4β...
19 October 2026 - Japan-based biopharmaceutical company Takeda (TSE: 4502) (NYSE: TAK) announced on Monday that positive Phase IV VERDICT trial results show that treating adults with moderate to severe ulcerative colitis with ENTYVIO (vedolizumab) to...